AXGN
Axogen Inc
NASDAQ: AXGN · HEALTHCARE · MEDICAL DEVICES
$43.20
+3.42% today
Updated 2026-04-30
Market cap
$2.22B
P/E ratio
—
P/S ratio
9.33x
EPS (TTM)
$-0.64
Dividend yield
—
52W range
$9 – $46
Volume
1.1M
Axogen Inc (AXGN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-13.20%
Operating margin
-4.61%
ROE
-18.00%
ROA
-2.32%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $126660.00 | $-367182.00 | 100.00% | -313.74% | -289.90% |
| 2007 | $100431.00 | $-748980.00 | 100.00% | -796.49% | -745.77% |
| 2008 | $72711.00 | $-1.04M | 100.00% | -1,453.41% | -1,431.30% |
| 2009 | $24.91M | $15.05M | 100.00% | 64.05% | 60.40% |
| 2010 | $91273.00 | $-1.32M | 100.00% | -2,025.27% | -1,442.16% |
| 2011 | $4.85M | $-9.22M | 49.96% | -143.70% | -190.11% |
| 2012 | $7.69M | $-9.42M | 74.49% | -101.43% | -122.44% |
| 2013 | $10.95M | $-14.56M | 77.71% | -87.62% | -132.97% |
| 2014 | $16.82M | $-17.71M | 79.53% | -58.28% | -105.31% |
| 2015 | $27.33M | $-13.36M | 82.26% | -33.91% | -48.87% |
| 2016 | $41.11M | $-14.41M | 84.27% | -19.78% | -35.06% |
| 2017 | $60.43M | $-10.45M | 84.59% | -13.16% | -17.29% |
| 2018 | $83.94M | $-22.40M | 84.60% | -24.42% | -26.68% |
| 2019 | $106.71M | $-29.12M | 83.74% | -29.43% | -27.29% |
| 2020 | $112.30M | $-23.79M | 80.78% | -20.64% | -21.18% |
| 2021 | $127.36M | $-26.98M | 81.99% | -19.96% | -21.19% |
| 2022 | $138.58M | $-28.95M | 78.51% | -21.44% | -20.89% |
| 2023 | $159.01M | $-21.72M | 76.64% | -13.50% | -13.66% |
| 2024 | $187.34M | $-9.96M | 75.79% | -1.75% | -5.32% |
| 2025 | $225.21M | $-15.70M | 74.31% | -3.49% | -6.97% |